[1]王瑶 姚远 张宁 雷霞 刘斌 刘国良.补骨脂素抗增生性瘢痕作用机制研究[J].国际中医中药杂志,2020,42(03):236-241.[doi:10.3760/cma.j.cn115398-20190520-00122]
 Wang Yao,Yao Yuan,Zhang Ning,et al.The mechanism of anti-proliferative scar of psoralen[J].,2020,42(03):236-241.[doi:10.3760/cma.j.cn115398-20190520-00122]
点击复制

补骨脂素抗增生性瘢痕作用机制研究

参考文献/References:

[1] Scott PG,Ghahary A,Tredget EE. Molecular and cellular aspects of fibrosis following thermal injury[J]. Hand Clin,2000, 16(2):271-287.

[2] Mreich E,Chen XM,Zaky A,et al. The role of Krüppel-like factor 4 in transforming growth factor-β-induced inflammatory and fibrotic responses in human proximal tubule cells[J]. Clin Exp Pharmacol Physiol,2015,42(6):680-686. DOI:10.1111/ 1440-1681.12405.

[3] Zhang Z,Li XJ,Liu Y,et al. Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts[J]. Burns,2007, 33(5):634-641. DOI:10.1016/j.burns.2006.08.018.

[4] Gunaratne A,Chan E,El-Chabib TH,et al. aPKC alters the TGFβ response in NSCLC cells through both Smad-dependent and Smad-independent pathways[J]. J Cell Sci,2015,128(3): 487-498. DOI:10.1242/jcs.155440.

[5] Shi Y,Massagué J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus[J]. Cell,2003,113(6):685-700. DOI:10.1016/s0092-8674(03)00432-x.

[6] Izzi L,Attisano L. Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation[J]. Oncogene,2004,23(11): 2071-2078. DOI:10.1038/sj.onc.1207412.

[7] Cai Y,Shen XZ,Zhou CH,et al. Abnormal expression of Smurf2 during the process of rat liver fibrosis[J]. Chin J Dig Dis,2006,7(4):237-245. DOI:10.1111/j.1443-9573.2006.00275.x.

[8] Fukasawa H,Yamamoto T,Togawa A,et al. Ubiquitin- dependent degradation of SnoN and Ski is increased in renal fibrosis induced by obstructive injury[J]. Kidney Int,2006, 69(10):1733-1740. DOI:10.1038/sj.ki.5000261.

[9] Ghahary A,Shen YJ,Scott PG,et al. Enhanced expression of mRNA for transforming growth factor-beta,type I and type III procollagen in human post-burn hypertrophic scar tissues[J]. J Lab Clin Med,1993,122(4):465-473.

[10] Tredget EE,Wang R,Shen Q,et al. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts:antagonism by IFN-alpha and IFN-gamma in vitro and in vivo[J]. J Interferon Cytokine Res,2000,20(2): 143-151. DOI:10.1089/107999000312540.

[11] Wang R,Ghahary A,Shen Q,et al. Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells[J]. Wound Repair Regen,2000,8(2):128-137. DOI:10.1046/j.1524-475x.2000. 00128.x.

[12] Scott PG,Dodd CM,Tredget EE,et al. Immunohistochemical localization of the proteoglycans decorin,biglycan and versican and transforming growth factor-beta in human post-burn hypertrophic and mature scars[J]. Histopathology,1995,26(5): 423-431. DOI:10.1111/j.1365-2559.1995.tb00249.x.

[13] Shah M,Foreman DM,Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring[J]. J Cell Sci, 1995,108(Pt 3):985-1002.

[14] Massagué J. How cells read TGF-beta signals[J]. Nat Rev Mol Cell Biol,2000,1(3):169-178. DOI:10.1038/35043051.

[15] Luo K. Ski and SnoN:negative regulators of TGF-beta signaling[J]. Curr Opin Genet Dev,2004,14(1):65-70. DOI:10.1016/j.gde.2003.11.003.

[16] Datto M,Wang XF. Ubiquitin-mediated degradation a mechanism for fine-tuning TGF-beta signaling[J]. Cell,2005, 121(1):2-4. DOI:10.1016/j.cell.2005.03.017.

[17] Itoh S,Dijke PT. Negative regulation of TGF-beta receptor/Smad signal transduction[J]. Curr Opin Cell Biol,2007,19(2): 176-184. DOI:10.1016/j.ceb.2007.02.015.

[18] Chong PA,Lin H,Wrana JL,et al. An expanded WW domain recognition motif revealed by the interaction between Smad7 and the E3 ubiquitin ligase Smurf2[J]. J Biol Chem,2006,281(25): 17069-17075. DOI:10.1074/jbc.M601493200.

[19] Asano Y,Ihn H,Yamane K,et al. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts[J]. J Clin Invest,2004, 113(2):253-264. DOI:10.1172/JCI16269.

[20] Schmid P,Itin P,Cherry G,et al. Enhanced expression of transforming growth factor-β type I and type II receptors in wound granulation tissue and hypertrophic scar[J]. American Journal of Pathology,1998,152(2):485-493. DOI:10.1006/ brln.1997.1886.

[21] Tomasek JJ,Gabbiani G,Hinz B,et al. Myofibroblasts and mechano-regulation of connective tissue remodelling[J]. Nat Rev Mol Cell Biol,2002,3(5):349-363. DOI:10.1038/nrm809.

[22] Tuan TL,Nichter LS. The molecular basis of keloid and hypertrophic scar formation[J]. Mol Med Today,1998,4(1): 19-24. DOI:10.1016/S1357-4310(97)80541-2.

[23] Zhang K,Garner W,Cohen L,et al. Increased types I and III collagen and transforming growth factor-beta 1 mRNA and protein in hypertrophic burn scar[J]. J Invest Dermatol,1995, 104(5):750-754. DOI:10.1111/1523-1747.ep12606979.

相似文献/References:

[1]黄敬文 韩雪 赵旭 李续博 董兴中 安丽凤 季顺欣 夏祥河.基于网络药理学的三七治疗和改善瘢痕增生分子机制研究 [J].国际中医中药杂志,2019,41(12):1353.[doi:10.3760/cma.j.issn.1673-4246.2019.12.016]
 Huang Jingwen,Han Xue,Zhao Xu,et al.Treatment and improvement of scar hyperplasia by panax notoginseng based on network pharmacology study on molecular mechanisms[J].,2019,41(03):1353.[doi:10.3760/cma.j.issn.1673-4246.2019.12.016]

备注/Memo

通信作者:刘斌,Email: 2214540333@qq.com,电话:0454-6105557

基金项目:黑龙江省博士后资助项目(LBH-Z16200);哈尔滨市科技局青年后备人才(2017RAQXJ184);黑龙江中医药大学校科研基金项目(2017xy04、201516、201726、201718)

更新日期/Last Update:

2020-03-18